FMP

FMP

Enter

BIAF - bioAffinity Technologies, Inc.

Profile of bioAffinity Technologies, Inc.(BIAF), bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnost

photo-url-https://financialmodelingprep.com/image-stock/BIAF.png

bioAffinity Technologies, Inc.

BIAF

NASDAQ

2.02 USD

-0.06 (-2.97%)

About

ceo

Ms. Maria Zannes J.D.

sector

Healthcare

industry

Diagnostics & Research

website

https://www.bioaffinitytech.com

exchange

NASDAQ

Description

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

CIK

0001712762

ISIN

US09076W1099

CUSIP

N/A

Address

22211 West Interstate 10

Phone

210 698 5334

Country

US

Employee

14

IPO Date

Sep 1, 2022

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep